Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mirat Shah"'
Autor:
Harpreet Singh, Laleh Amiri-Kordestani, Amy Barone, Richard Pazdur, Mirat Shah, Janice Kim, Suparna Wedam, Diana Bradford, Gautam U Mehta, Erin Larkins, Adnan A. Jaigirdar, Marc R. Theoret, Lee Pai-Scherf, Julia A. Beaver
Publikováno v:
Journal of Neuro-Oncology
Objective Contemporary management of patients with neuro-oncologic disease requires an understanding of approvals by the US Food and Drug Administration (FDA) related to nervous system tumors. To summarize FDA updates applicable to neuro-oncology pra
Autor:
Phyllis Dvora Corn, Dan Ariely, Ravi Varadhan, Anna Ferguson, B. Douglas Smith, Mirat Shah, Benjamin W. Corn, Vered Stearns, Thomas J. Smith
Publikováno v:
JCO Oncol Pract
PURPOSE: Hope is a modifiable entity that can be augmented. We evaluated the feasibility, acceptability, and efficacy of a short intervention to increase hopefulness in patients with advanced breast cancer and oncologists. METHODS: We enrolled eligib
Autor:
Wei Chen, Marc R. Theoret, Pengfei Song, Xiao Hong Chen, Shenghui Tang, Kirsten B. Goldberg, Yutao Gong, Mallorie H. Fiero, Tiffany K. Ricks, William F. Pierce, Richard Pazdur, Joyce Cheng, Jianghong Fan, Fang Li, Mirat Shah, Suparna Wedam, Jingyu Yu, Laleh Amiri-Kordestani, Julia A. Beaver, Huiming Xia, Xinyuan Zhang
Publikováno v:
Clinical Cancer Research. 27:1220-1226
On April 17, 2020, the FDA approved tucatinib in combination with trastuzumab and capecitabine for the treatment of patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases, who have rece
Autor:
Aaron R. Hansen, Mirat Shah, Marianna Zahurak, Adrian Murphy, Noelle K. LoConte, Nilofer S. Azad, Barry D. Nelkin, Anirban Maitra, Lillian L. Siu, Etctn Study Team, Anna Spreafico, Nicole M. Anders, L. Austin Doyle, Michelle A. Rudek, Tearra Miles, Colin D. Weekes
Publikováno v:
Clinical and Translational Science
The combination of drugs targeting Ral and PI3K/AKT signaling has antitumor efficacy in preclinical models of pancreatic cancer. We combined dinaciclib (small molecule cyclin dependent kinase inhibitor with MK‐2206 (Akt inhibitor) in patients with
Autor:
Melinda Hsu, Arjun Gupta, Ilene S. Browner, Marcus Messmer, Kristen A. Marrone, Mirat Shah, Thomas J. Smith, Ramy Sedhom, Joseph C. Murray
Publikováno v:
JCO Oncol Pract
PURPOSE: ASCO guidelines recommend palliative care (PC) referral for patients with advanced or metastatic cancer. Despite this, implementation has considerable hurdles. First-year oncology fellows at our institution identified low rates of PC utiliza
Publikováno v:
Journal of Oncology Practice. 12:1208-1210
Autor:
Sarah Beth Kitchen, Yongjua Laosiritaworn, Derek A. T. Cummings, Shawn T. Brown, Bruce Y. Lee, Donald S. Burke, Mirat Shah, Kristina M. Bacon, Diana L. Connor, Rachel R. Bailey
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
With several candidate dengue vaccines under development, this is an important time to help stakeholders (e.g., policy makers, scientists, clinicians, and manufacturers) better understand the potential economic value (cost-effectiveness) of a dengue